NWD1 Activators
NWD1 utilize various molecular pathways to modulate the protein's activity. Forskolin, a plant-derived compound, directly interacts with adenylate cyclase, which catalyzes the conversion of ATP to cAMP. An increase in intracellular levels of cAMP can lead to the activation of protein kinase A (PKA). Once activated, PKA can phosphorylate target proteins, including NWD1, leading to its activation. Similarly, IBMX raises cAMP levels by inhibiting phosphodiesterases, enzymes responsible for the breakdown of cAMP. This inhibition contributes to a sustained PKA activation state, which can phosphorylate and activate NWD1. Prostaglandin E2 (PGE2) works through G protein-coupled receptors to activate adenylate cyclase, again influencing the cAMP-PKA signaling pathway and potentially leading to the phosphorylation of NWD1. Isoproterenol and epinephrine, both agonists of beta-adrenergic receptors, also stimulate adenylate cyclase, increasing cAMP levels and activating PKA, which is known to phosphorylate various proteins including NWD1.
NWD1 include anisomycin, which activates the JNK pathway, potentially leading to the transcription of genes involved in the full activation of NWD1. PDBu, a known activator of protein kinase C (PKC), can phosphorylate proteins that may interact with NWD1, influencing its activation status. The calcium ionophores, ionomycin and A23187, raise intracellular calcium levels, which in turn can activate calcium-dependent kinases such as PKC, offering another means by which NWD1 may be phosphorylated and activated. Lysophosphatidic acid activates G protein-coupled receptors and can initiate signaling cascades involving kinases like Rho kinase, which may phosphorylate NWD1. Okadaic acid, through its inhibition of protein phosphatases PP1 and PP2A, can prevent the dephosphorylation of proteins, thereby maintaining NWD1 in a phosphorylated, active state. Lastly, rolipram elevates cAMP levels by inhibiting phosphodiesterase 4, leading to PKA activation, which can phosphorylate and thus activate NWD1. Each of these chemicals, through their unique interactions with cellular signaling pathways, can contribute to the regulation of NWD1 activity within the cell.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases which increases intracellular cAMP by preventing its breakdown. Elevated cAMP may activate PKA, thereby phosphorylating and activating NWD1. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) engages G protein-coupled receptors, which can lead to the activation of adenylate cyclase and subsequent cAMP production. cAMP acts as a second messenger to activate PKA, potentially leading to NWD1 activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that stimulates adenylate cyclase activity via G protein-coupled receptor signaling, leading to increased cAMP and PKA activation, which could phosphorylate and activate NWD1. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to beta-adrenergic receptors, stimulating adenylate cyclase and raising cAMP levels, which activates PKA. PKA activation is a potential mechanism for NWD1 activation through phosphorylation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can lead to the activation of transcription factors which may enhance the transcription of downstream targets required for the full activity of NWD1. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent kinases such as PKC, which could in turn phosphorylate and activate NWD1. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic acid (LPA) activates G protein-coupled receptors, leading to activation of multiple downstream kinases, such as Rho kinase, which may then phosphorylate and activate NWD1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A; inhibition of these phosphatases can lead to increased phosphorylation levels of proteins, potentially including NWD1, thus leading to its activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium, which could activate calcium/calmodulin-dependent protein kinases and potentially lead to the activation of NWD1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, leading to an increase in cAMP levels, which may activate PKA, providing a possible pathway for the phosphorylation and activation of NWD1. | ||||||